A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

Stopped early · Phase 3

Conditions studied: Iron Deficiency Anemia

In brief

Study evaluating the efficacy and safety of intravenous (IV) ferumoxytol compared with oral iron for the treatment of pediatric participants with chronic kidney disease (CKD).

Key facts

Study ID

NCT01155375

Run by

AMAG Pharmaceuticals, Inc.

People needed

14

Starts

2011-10-17

Expected to finish

2014-06-24

Last updated by the study team

2022-04-04

Who can join

Age: 1 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

• AMAG Pharmaceuticals, Inc. — Waltham, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.